14:00 - 14:15 Opening ceremony

14:15 - 15:30 Session 1: AML

14:15 - 14:45  Overview Presentation

• Virtual Room A
  Update on AML
  K Döhner (Germany)

14:45 - 15:30 Parallel Expert break-out sessions

• Virtual Room A
  Management of Elderly AML patients
  Speaker: İ Alacacıoğlu (Turkey)
  Chair: G Ossenkoppele (The Netherlands)
• Virtual Room B
  Down syndrome in AML
  S Izraeli (Israel)
  Chair: H Oren (Turkey)
  
  
• Virtual Room C
  Treatment of pediatric AML
  GJ Kaspers (The Netherlands)
  Chair: V Hazar (Turkey)

15:30 - 15:45 A moment to stretch & relax

15:45 - 17:00 Session 2: MDS

15:45 - 16:15 Overview Presentation

• Virtual Room A
  Update on MDS
  P Fenaux (France)
  Chair: İ Alacacıoğlu (Turkey)

16:15 - 17:00 Parallel Expert break-out sessions

• Virtual Room A
  To be defined based on overview lecture
  P Fenaux (France)
  Chair: İ Alacacıoğlu (Turkey)
  
  
• Virtual Room B
  Germline mutations and risk of bone marrow failure and MDS
  J Soulier (France)
  Chair: S Izraeli (Israel)
  
  
• Virtual Room C
  Understanding the pathophysiology: Risk based treatment of MDS in 2020
  A Almeida (Portugal)
  Chair: AM Demir (Turkey)

17:00 - 17:15 A moment to stretch & relax

17:15 - 17:45 Satellite Symposium Janssen: A look into the future: How might we identify the most appropriate cellular therapy for patients with Multiple Myeloma?

17:45 - 19:00 Session 3: Plasma cell disorders

17:45 - 18:15 Overview Presentation

• Virtual Room A
  Update on multiple myeloma
  Speaker: M Beksaç (Turkey)
  Chair: GH Özsan (Turkey)

18:15 - 19:00  Parallel Expert break-out sessions

• Virtual Room A
  Risk assessment at diagnosis and risk based therapy
  Speaker: M Beksaç (Turkey)
  Chair: GH Özsan (Turkey)
  
  
• Virtual Room B
  Diagnosis and current management of AL amyloidosis
  G Palladini (Italy)
  Chair: A Salihoğlu (Turkey)
  
  
• Virtual Room C
  Diagnosis and treatment of high risk MM: Update 2020 (incl. immunotherapies)
  M Cavo (Italy)
  Chair: ÖG Sevindik (Turkey)

19:00 - 19:15  Close of Day 1

09:00 Opening day 2

09:00 - 09:30 Keynote Lecture 1

• Virtual Room A
  CAR T cells in 2020
  A Urbano-Ispizua (Spain)
  Chair: J Gribben (United Kingdom)

09:30 – 10:45 Session 4: Myeloproliferative neoplasms

09:30 – 10:00  Overview Presentation

• Virtual Room A
  Update on MPN
  A Almeida (Portugal)
  Chair: MC Ar (Turkey)

10:00 – 10:45 Parallel Expert break-out sessions

• Virtual Room A
  When to start and stop ruxolitinib in MF?
  A Almeida (Portugal)
  Chair: MC Ar (Turkey)
  
  
• Virtual Room B
  Current standards in the diagnosis and treatment of mastocytosis
  Speaker SA Yavuz (Turkey)
  Chair: N Andıç (Turkey)
  
  
• Virtual Room C
  Challenges in SCT in myelofibrosis
  E Ollavaria (United Kingdom)
  Chair: D Wolf (Austria)

10:45 - 11:00 A moment to stretch & relax

11:00 - 12:15 Session 5: Lymphoproliferative disorders

11:00 - 11:30  Overview Presentation

• Virtual Room A
  Update on lymphoma
  G Gaidano (Italy)
  Chair: J Gribben (United Kingdom)

11:30 – 12:15 Parallel Expert break-out sessions

• Virtual Room A
  To be defined based on overview lecture
  G Gaidano (Italy)
  J Gribben (United Kingdom)
  
  
• Virtual Room B
  Molecular classification and treatment of aggressive B-cell lymphomas
  A Davies (United Kingdom)
  Chair: M Özcan (Turkey)
  
  
• Virtual Room C
  Molecular classification and biomarker driven therapies in T-cell lymphomas
  R Koch (Germany)
  Chair: EB Ateşoğlu (Turkey)

12:15 - 13:15 Time for Lunch!

12:45 - 13:15 Satellite Symposium Amgen: Blinatumomab in the treatment of acute lymphoblastic leukemia

13:15 - 13:45 Keynote Lecture 2

• Virtual Room A
  CLL
  J Gribben (United Kingdom)
  Chair: GH Özsan (Turkey)

13:45 - 15:00 Session 6: Benign hematology

13:45 - 14:15 Overview Presentation

• Virtual Room A
  Update on VTE
  R Kucukkaya (Turkey)
  Chair: MC Ar (Turkey)

14:15 - 15:00 Parallel Expert break-out sessions

• Virtual Room A
  Cancer associated thrombosis
  R Kucukkaya (Turkey)
  Chair: MC Ar (Turkey)
  
  
• Virtual Room B
  TTP versus HUS: Understanding the disease
  M Scully (United Kingdom)
  Chair: N Andıç (Turkey)
  
  
• Virtual Room C
  Current understanding and management of DIC
  CH Toh (United Kingdom)
  Chai: S Eichinger (Austria)

15:00 - 15:15 A moment to stretch & relax

15:15 - 15:45 Satellite Symposium by Roche: Setting the new norm in the treatment of Follicular Lymphoma

15:45 - 16:30 EHA-TSH Joint Symposium

• Virtual Room A
  Iron Overload and Monitoring in Hemoglobinopathies
  Ş Ünal Cangül (Turkey)
  Chair: GH Özsan (Turkey)
  New therapeutic approaches for hemoglobinopathies
  MD Cappellini (Italy)
  J Gribben (United Kingdom)

16:30 Closing Remarks